-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOMARIN PHARMACEUTICAL - AND N-LOREM ANNOUNCE GLOBAL EXCLUSIVE LICENSE TO DEVELOP ASO MEDICINE FOR RENU SYNDROME

Reuters·07/27/2026 13:08:03

Please log in to view news